Corcept Therapeutics (CORT) Inventory Average (2012 - 2026)

Corcept Therapeutics has reported Inventory Average for 15 years, with the latest figure at $13.0 million in Q2 2026.

• Quarterly Inventory Average fell 2.14% year-over-year to $13.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $13.0 million (down 2.14% YoY) and the FY2025 annual result came in at $12.6 million, up 25.51% from the prior year.
• Inventory Average advanced to $13.0 million in Q2 2026 per CORT's latest filing, from $12.9 million in the prior quarter.
• Over five years, Inventory Average peaked at $13.4 million in Q1 2025 and troughed at $5.0 million in Q1 2022.
• A 5-year average of $8.9 million and a median of $7.7 million in 2023 frame the typical range for Inventory Average.
• The sharpest annual moves came in 2025 and 2026: Inventory Average surged 79.49% in 2025, then dropped 3.82% in 2026.
• Over 5 years, Inventory Average stood at $6.1 million in 2022, then grew by 25.5% to $7.6 million in 2023, then surged by 34.24% to $10.2 million in 2024, then advanced by 23.24% to $12.6 million in 2025, then grew by 3.4% to $13.0 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $13.0 million, $12.9 million, and $12.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.